Recipharm Holding India Profile
Key Indicators
- Authorised Capital ₹ 48.00 Cr
as on 24-10-2024
- Paid Up Capital ₹ 43.72 Cr
as on 24-10-2024
- Company Age 8 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -63.72%
(FY 2023)
- Profit -64.13%
(FY 2023)
- Ebitda -74.75%
(FY 2023)
- Net Worth -8.46%
(FY 2023)
- Total Assets -8.68%
(FY 2023)
About Recipharm Holding India
The Company is engaged in the Financial Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 48.00 Cr and a paid-up capital of Rs 43.72 Cr, as per Ministry of Corporate Affairs (MCA) records.
The Key Managerial Personnel (KMP) at Recipharm Holding India Private Limited India is Suresh Ganachari as COMPANY SECRETARY. Suresh Ganachari, Emmanuel Grand, and Rohit Sidhwani serve as directors at the Company.
- CIN/LLPIN
U74999HP2016FTC001175
- Company No.
001175
- Company Classification
Private Limited Foreign Company Incorporated In India
- Incorporation Date
15 Mar 2016
- Date of AGM
29 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Himachal Pradesh
Industry
Company Details
- Location
Sirmaur, Himachal Pradesh, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Recipharm Holding India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Suresh Ganachari  | Company Secretary | 26-Jul-2024 | Current |
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Suresh Ganachari | Director and Company Secretary | 28-Nov-2022 | Current |
| Emmanuel Grand | Director | 06-Jan-2023 | Current |
| Rohit Sidhwani | Director | 22-Feb-2023 | Current |
Financial Performance and Corporate Structure Insights of Recipharm Holding India.
Recipharm Holding India Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 63.72% decrease. The company also saw a substantial fall in profitability, with a 64.13% decrease in profit. The company's net worth dipped by a decrease of 8.46%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Recipharm Holding India?
In 2023, Recipharm Holding India had a promoter holding of 100.00%. The company had 3 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Recipharm Pharmaservices Private LimitedActive 8 years 11 monthsSuresh Ganachari and Suresh Ganachari are mutual person
Recipharm Lifesciences India Private LimitedActive 7 years 10 monthsSuresh Ganachari, Emmanuel Grand and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Recipharm Holding India?
Unlock and access historical data on people associated with Recipharm Holding India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Recipharm Holding India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Recipharm Holding India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
